• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TOTAL PSA; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TOTAL PSA; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS Back to Search Results
Catalog Number 08791732190
Medical Device Problem Code Output Problem (3005)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/04/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The e801 analyzer serial number was (b)(6).
 
Event or Problem Description
The initial reporter complained of high results for multiple patient samples tested for elecsys free psa (free psa) on a cobas e 801 analytical unit.The free psa results were higher than the elecsys total psa (total psa) results.This medwatch will cover total psa.Refer to medwatch with a1 patient identifier (b)(6) for information on the free psa results.Examples of questionable results were provided for 3 patient samples.Patient 1 free psa result was 0.0176 ng/ml.The total psa result was 0.0073 ng/ml.Patient 2 free psa result was 0.0166 ng/ml.The total psa result was 0.006 ng/ml with a data flag.On (b)(6) 2025 patient 3 free psa result was 0.0203 ng/ml.The total psa result was 0.0110 ng/ml.
 
Additional Manufacturer Narrative
Section d4, lot number, and expiration date were updated.Calibration and qc were acceptable.No issues were identified during a review of the alarm trace data.No instrument maintenance issues were identified.The patient samples were not available for further investigation; therefore, the cause of the event could not be determined.A general reagent problem can be excluded as qc was within range.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TOTAL PSA
Common Device Name
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key22893287
Report Number1823260-2025-02613
Device Sequence Number15692787
Product Code MTF
UDI-Device Identifier07613336165980
UDI-Public07613336165980
Combination Product (Y/N)N
Initial Reporter CountryBR
PMA/510(K) Number
P990056/S039
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/08/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2026
Device Catalogue Number08791732190
Device Lot Number865283
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 08/05/2025
Supplement Date Received by Manufacturer11/24/2025
Initial Report FDA Received Date08/26/2025
Supplement Report FDA Received Date12/08/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-